Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States)

Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW.

Cancer Causes Control. 1995 May;6(3):235-9.

PMID:
7612803
2.

Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis.

Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW.

Am J Epidemiol. 1995 Sep 15;142(6):608-11.

PMID:
7653469
3.

Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.

Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ.

Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):121-6.

4.

Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.

Ma J, Stampfer MJ, Gann PH, Hough HL, Giovannucci E, Kelsey KT, Hennekens CH, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):385-90.

5.

Vitamin D and prostate cancer: a prediagnostic study with stored sera.

Corder EH, Guess HA, Hulka BS, Friedman GD, Sadler M, Vollmer RT, Lobaugh B, Drezner MK, Vogelman JH, Orentreich N.

Cancer Epidemiol Biomarkers Prev. 1993 Sep-Oct;2(5):467-72.

6.

Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.

Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1991-7.

7.

Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States)

Nomura AM, Stemmermann GN, Lee J, Kolonel LN, Chen TC, Turner A, Holick MF.

Cancer Causes Control. 1998 Aug;9(4):425-32.

PMID:
9794175
8.

Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer.

Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, Helzlsouer KJ.

Am J Epidemiol. 2003 Feb 15;157(4):335-44. Erratum in: Am J Epidemiol. 2003 Jun 15;157(12):1126.

PMID:
12578804
9.

Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer.

Tuohimaa P, Tenkanen L, Syvälä H, Lumme S, Hakulinen T, Dillner J, Hakama M.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):302-7.

10.

Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men.

Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, Virtamo J, Albanes D.

Cancer Causes Control. 1997 Jul;8(4):615-25.

PMID:
9242478
11.

Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer.

Jacobs ET, Giuliano AR, Martínez ME, Hollis BW, Reid ME, Marshall JR.

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):533-7.

PMID:
15225833
12.

Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland).

Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P.

Cancer Causes Control. 2000 Oct;11(9):847-52.

PMID:
11075874
13.

Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.

Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ.

Cancer Res. 1999 Mar 15;59(6):1225-30.

14.

Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.

Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E.

Cancer Causes Control. 2004 Apr;15(3):255-65.

PMID:
15090720
15.

Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.

Peters U, Hayes RB, Chatterjee N, Shao W, Schoen RE, Pinsky P, Hollis BW, McGlynn KA; Prostate, Lung, Colorectal and Ovarian Cancer Screening Project Team..

Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):546-52.

16.

Association of prostate cancer with vitamin D receptor gene polymorphism.

Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA.

Cancer Res. 1996 Sep 15;56(18):4108-10.

17.

Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.

Vatten LJ, Ursin G, Ross RK, Stanczyk FZ, Lobo RA, Harvei S, Jellum E.

Cancer Epidemiol Biomarkers Prev. 1997 Nov;6(11):967-9.

18.

Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.

Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D.

Cancer Res. 2003 Jul 15;63(14):3991-4.

19.

Serologic precursors of cancer. I. Prediagnostic serum nutrients and colon cancer risk.

Schober SE, Comstock GW, Helsing KJ, Salkeld RM, Morris JS, Rider AA, Brookmeyer R.

Am J Epidemiol. 1987 Dec;126(6):1033-41.

PMID:
3687915
20.

Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer.

Tworoger SS, Lee IM, Buring JE, Rosner B, Hollis BW, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):783-8.

Supplemental Content

Support Center